Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Influenza

Free Subscription Articles published in Virology Retrieve available abstracts of 102 articles: HTML format Text format

Single Articles

January 2019
1. SANADA T, Yasui F, Honda T, Kayesh MEH, et al
   Avian H5N1 influenza virus infection causes severe pneumonia in the Northern tree shrew (Tupaia belangeri).
   Virology. 2019;529:101-110.
   PubMed     Text format     Abstract available
   
   
   
2. LEE YT, Kim KH, Ko EJ, Kim MC, et al
   Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles.
   Virology. 2019;529:111-121.
   PubMed     Text format     Abstract available
   
   
   
3. KWON JH, Noh JY, Jeong JH, Jeong S, et al
   Different pathogenicity of two strains of clade 2.3.4.4c H5N6 highly pathogenic avian influenza viruses bearing different PA and NS gene in domestic ducks.
   Virology. 2019;530:11-18.
   PubMed     Text format     Abstract available
   
   
   
4. SREENIVASAN CC, Thomas M, Antony L, Wormstadt T, et al
   Development and characterization of swine primary respiratory epithelial cells and their susceptibility to infection by four influenza virus types.
   Virology. 2019;528:152-163.
   PubMed     Text format     Abstract available
   
   
   
5. LIU L, Wang T, Wang M, Tong Q, et al
   Recombinant turkey herpesvirus expressing H9 hemagglutinin providing protection against H9N2 avian influenza.
   Virology. 2019;529:7-15.
   PubMed     Text format     Abstract available
   
   
   
6. ZOU S, Zhang Y, Li X, Bo H, et al
   Molecular characterization and receptor binding specificity of H9N2 avian influenza viruses based on poultry-related environmental surveillance in China between 2013 and 2016.
   Virology. 2019;529:135-143.
   PubMed     Text format     Abstract available
   
   
   
7. NIKOLAIDIS M, Mimouli K, Kyriakopoulou Z, Tsimpidis M, et al
   Large-scale genomic analysis reveals recurrent patterns of intertypic recombination in human enteroviruses.
   Virology. 2019;526:72-80.
   PubMed     Text format     Abstract available
   
   
   December 2018
8. MA LL, Zhang P, Wang HQ, Li YF, et al
   heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-alpha/beta.
   Virology. 2018;528:80-88.
   PubMed     Text format     Abstract available
   
   
   
9. OHTSUKA J, Matsumoto Y, Ohta K, Fukumura M, et al
   Nucleocytoplasmic shuttling of the human parainfluenza virus type 2 phosphoprotein.
   Virology. 2018;528:54-63.
   PubMed     Text format     Abstract available
   
   
   November 2018
10. HIONO T, Matsuda A, Wagatsuma T, Okamatsu M, et al
    Lectin microarray analyses reveal host cell-specific glycan profiles of the hemagglutinins of influenza A viruses.
    Virology. 2018;527:132-140.
    PubMed     Text format     Abstract available
    
    
    
11. BELSER JA, Maines TR, Tumpey TM
    Importance of 1918 virus reconstruction to current assessments of pandemic risk.
    Virology. 2018;524:45-55.
    PubMed     Text format     Abstract available
    
    
    October 2018
12. NICOL MQ, Campbell GM, Shaw DJ, Dransfield I, et al
    Lack of IFNgamma signaling attenuates spread of influenza A virus in vivo and leads to reduced pathogenesis.
    Virology. 2018;526:155-164.
    PubMed     Text format     Abstract available
    
    
    
13. WANG SC, Liao HY, Zhang JY, Cheng TR, et al
    Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris.
    Virology. 2018;526:125-137.
    PubMed     Text format     Abstract available
    
    
    
14. ZHANG J, Ruan T, Sheng T, Wang J, et al
    Role of c-Jun terminal kinase (JNK) activation in influenza A virus-induced autophagy and replication.
    Virology. 2018;526:1-12.
    PubMed     Text format     Abstract available
    
    
    
15. MARCHENKO V, Goncharova N, Susloparov I, Kolosova N, et al
    Isolation and characterization of H5Nx highly pathogenic avian influenza viruses of clade 2.3.4.4 in Russia.
    Virology. 2018;525:216-223.
    PubMed     Text format     Abstract available
    
    
    
16. NARKPUK J, Jongkaewwattana A, Teeravechyan S
    The avian influenza virus PA segment mediates strain-specific antagonism of BST-2/tetherin.
    Virology. 2018;525:161-169.
    PubMed     Text format     Abstract available
    
    
    
17. GONZALEZ-PARRA G, Dobrovolny HM
    A quantitative assessment of dynamical differences of RSV infections in vitro and in vivo.
    Virology. 2018;523:129-139.
    PubMed     Text format     Abstract available
    
    
    
18. MORGENE MF, Maurin C, Pillet S, Berthelot P, et al
    HaCaT epithelial cells as an innovative novel model of rhinovirus infection and impact of clarithromycin treatment on infection kinetics.
    Virology. 2018;523:27-34.
    PubMed     Text format     Abstract available
    
    
    September 2018
19. YAN LM, Li OTW, Poh CM, Perera RAPM, et al
    Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection.
    Virology. 2018;525:73-82.
    PubMed     Text format     Abstract available
    
    
    
20. CUI L, Mahesutihan M, Zheng W, Meng L, et al
    CDC25B promotes influenza A virus replication by regulating the phosphorylation of nucleoprotein.
    Virology. 2018;525:40-47.
    PubMed     Text format     Abstract available
    
    
    
21. LI L, DeLiberto TJ, Killian ML, Torchetti MK, et al
    Evolutionary pathway for the 2017 emergence of a novel highly pathogenic avian influenza A(H7N9) virus among domestic poultry in Tennessee, United States.
    Virology. 2018;525:32-39.
    PubMed     Text format     Abstract available
    
    
    
22. XIAO Y, Nolting JM, Sheng ZM, Bristol T, et al
    Design and validation of a universal influenza virus enrichment probe set and its utility in deep sequence analysis of primary cloacal swab surveillance samples of wild birds.
    Virology. 2018;524:182-191.
    PubMed     Text format     Abstract available
    
    
    
23. KIM KH, Kwon YM, Lee YT, Hwang HS, et al
    Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.
    Virology. 2018;524:172-181.
    PubMed     Text format     Abstract available
    
    
    August 2018
24. OHTA K, Matsumoto Y, Yumine N, Nishio M, et al
    The V protein of human parainfluenza virus type 2 promotes RhoA-induced filamentous actin formation.
    Virology. 2018;524:90-96.
    PubMed     Text format     Abstract available
    
    
    
25. ZARUBAEV VV, Pushkina EA, Borisevich SS, Galochkina AV, et al
    Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity.
    Virology. 2018;524:69-77.
    PubMed     Text format     Abstract available
    
    
    
26. SHIBATA A, Okamatsu M, Sumiyoshi R, Matsuno K, et al
    Repeated detection of H7N9 avian influenza viruses in raw poultry meat illegally brought to Japan by international flight passengers.
    Virology. 2018;524:10-17.
    PubMed     Text format     Abstract available
    
    
    July 2018
27. SUTTIE A, Karlsson EA, Deng YM, Horm SV, et al
    Influenza A(H5N1) viruses with A(H9N2) single gene (matrix or PB1) reassortment isolated from Cambodian live bird markets.
    Virology. 2018;523:22-26.
    PubMed     Text format     Abstract available
    
    
    
28. WANG Z, Huang B, Thomas M, Sreenivasan CC, et al
    Detailed mapping of the linear B Cell epitopes of the hemagglutinin (HA) protein of swine influenza virus.
    Virology. 2018;522:131-137.
    PubMed     Text format     Abstract available
    
    
    
29. CORREIA V, Abecasis AB, Rebelo-de-Andrade H
    Molecular footprints of selective pressure in the neuraminidase gene of currently circulating human influenza subtypes and lineages.
    Virology. 2018;522:122-130.
    PubMed     Text format     Abstract available
    
    
    
30. SHCHERBIK S, Carney P, Pearce N, Stevens J, et al
    Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.
    Virology. 2018;522:65-72.
    PubMed     Text format     Abstract available
    
    
    
31. GAMBARYAN AS, Matrosovich TY, Boravleva EY, Lomakina NF, et al
    Receptor-binding properties of influenza viruses isolated from gulls.
    Virology. 2018;522:37-45.
    PubMed     Text format     Abstract available
    
    
    May 2018
32. LI Y, Sun L, Zheng W, Madina Mahesutihan, et al
    Phosphorylation and dephosphorylation of threonine 188 in nucleoprotein is crucial for the replication of influenza A virus.
    Virology. 2018;520:30-38.
    PubMed     Text format     Abstract available
    
    
    April 2018
33. LI J, Zhang K, Chen Q, Zhang X, et al
    Three amino acid substitutions in the NS1 protein change the virus replication of H5N1 influenza virus in human cells.
    Virology. 2018;519:64-73.
    PubMed     Text format     Abstract available
    
    
    March 2018
34. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Kotomina T, et al
    Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin.
    Virology. 2018;518:313-323.
    PubMed     Text format     Abstract available
    
    
    
35. CHRZASTEK K, Lee DH, Gharaibeh S, Zsak A, et al
    Characterization of H9N2 avian influenza viruses from the Middle East demonstrates heterogeneity at amino acid position 226 in the hemagglutinin and potential for transmission to mammals.
    Virology. 2018;518:195-201.
    PubMed     Text format     Abstract available
    
    
    February 2018
36. ZHANG S, Cheng Q, Luo C, Yin L, et al
    An alanine residue in human parainfluenza virus type 3 phosphoprotein is critical for restricting excessive N(0)-P interaction and maintaining N solubility.
    Virology. 2018;518:64-76.
    PubMed     Text format     Abstract available
    
    
    
37. RAMEY AM, DeLiberto TJ, Berhane Y, Swayne DE, et al
    Lessons learned from research and surveillance directed at highly pathogenic influenza A viruses in wild birds inhabiting North America.
    Virology. 2018;518:55-63.
    PubMed     Text format     Abstract available
    
    
    
38. RAJAO DS, Anderson TK, Kitikoon P, Stratton J, et al
    Antigenic and genetic evolution of contemporary swine H1 influenza viruses in the United States.
    Virology. 2018;518:45-54.
    PubMed     Text format     Abstract available
    
    
    January 2018
39. RODRIGUEZ L, Reedy S, Nogales A, Murcia PR, et al
    Development of a novel equine influenza virus live-attenuated vaccine.
    Virology. 2018;516:76-85.
    PubMed     Text format     Abstract available
    
    
    
40. OISHI K, Yamayoshi S, Kawaoka Y
    Identification of novel amino acid residues of influenza virus PA-X that are important for PA-X shutoff activity by using yeast.
    Virology. 2018;516:71-75.
    PubMed     Text format     Abstract available
    
    
    
41. LEE YN, Lee EK, Song BM, Heo GB, et al
    Evaluation of the zoonotic potential of multiple subgroups of clade 2.3.4.4 influenza A (H5N8) virus.
    Virology. 2018;516:38-45.
    PubMed     Text format     Abstract available
    
    
    December 2017
42. SUN H, Yao W, Wang K, Qian Y, et al
    Inhibition of neddylation pathway represses influenza virus replication and pro-inflammatory responses.
    Virology. 2017;514:230-239.
    PubMed     Text format     Abstract available
    
    
    
43. HERRERA-RODRIGUEZ J, Meijerhof T, Niesters HG, Stjernholm G, et al
    A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.
    Virology. 2017;515:21-28.
    PubMed     Text format     Abstract available
    
    
    November 2017
44. AUMAYR M, Schrempf A, Uzulmez O, Olek KM, et al
    Interaction of 2A proteinase of human rhinovirus genetic group A with eIF4E is required for eIF4G cleavage during infection.
    Virology. 2017;511:123-134.
    PubMed     Text format     Abstract available
    
    
    October 2017
45. NI F, Kondrashkina E, Wang Q
    Determinant of receptor-preference switch in influenza hemagglutinin.
    Virology. 2017;513:98-107.
    PubMed     Text format     Abstract available
    
    
    
46. LION A, Richard M, Esnault E, Kut E, et al
    Productive replication of avian influenza viruses in chicken endothelial cells is determined by hemagglutinin cleavability and is related to innate immune escape.
    Virology. 2017;513:29-42.
    PubMed     Text format     Abstract available
    
    
    
47. LAU JW, Kim YI, Murphy R, Newman R, et al
    Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics.
    Virology. 2017;510:289-296.
    PubMed     Text format     Abstract available
    
    
    
48. YE Z, Ren L, Tang Z, Deng Y, et al
    Pulmonary C-fiber degeneration downregulates IFN-gamma receptor 1 via IFN-alpha induction to attenuate RSV-induced airway hyperresponsiveness.
    Virology. 2017;510:262-272.
    PubMed     Text format     Abstract available
    
    
    September 2017
49. TAKEMAE N, Tsunekuni R, Sharshov K, Tanikawa T, et al
    Five distinct reassortants of H5N6 highly pathogenic avian influenza A viruses affected Japan during the winter of 2016-2017.
    Virology. 2017;512:8-20.
    PubMed     Text format     Abstract available
    
    
    
50. WILSON JR, Belser JA, DaSilva J, Guo Z, et al
    An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge.
    Virology. 2017;511:214-221.
    PubMed     Text format     Abstract available
    
    
    August 2017
51. CHEN W, Xu Q, Zhong Y, Yu H, et al
    Genetic variation and co-evolutionary relationship of RNA polymerase complex segments in influenza A viruses.
    Virology. 2017;511:193-206.
    PubMed     Text format     Abstract available
    
    
    
52. NAGUIB MM, Arafa AS, Parvin R, Beer M, et al
    Insights into genetic diversity and biological propensities of potentially zoonotic avian influenza H9N2 viruses circulating in Egypt.
    Virology. 2017;511:165-174.
    PubMed     Text format     Abstract available
    
    
    
53. BELSER JA, Johnson A, Pulit-Penaloza JA, Pappas C, et al
    Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.
    Virology. 2017;511:135-141.
    PubMed     Text format     Abstract available
    
    
    
54. HWANG HS, Lee YT, Kim KH, Ko EJ, et al
    Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.
    Virology. 2017;511:142-151.
    PubMed     Text format     Abstract available
    
    
    
55. ABENTE EJ, Gauger PC, Walia RR, Rajao DS, et al
    Detection and characterization of an H4N6 avian-lineage influenza A virus in pigs in the Midwestern United States.
    Virology. 2017;511:56-65.
    PubMed     Text format     Abstract available
    
    
    
56. ROJO GL, Goya S, Orellana M, Sancilio A, et al
    Unravelling respiratory syncytial virus outbreaks in Buenos Aires, Argentina: Molecular basis of the spatio-temporal transmission.
    Virology. 2017;508:118-126.
    PubMed     Text format     Abstract available
    
    
    July 2017
57. NGUYEN LT, Nishi T, Shichinohe S, Chu DH, et al
    Selection of antigenic variants of an H5N1 highly pathogenic avian influenza virus in vaccinated chickens.
    Virology. 2017;510:252-261.
    PubMed     Text format     Abstract available
    
    
    
58. BAJIMAYA S, Frankl T, Hayashi T, Takimoto T, et al
    Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses.
    Virology. 2017;510:234-241.
    PubMed     Text format     Abstract available
    
    
    
59. ALKHERAIF AA, Topliff CL, Reddy J, Massilamany C, et al
    Type 2 BVDV Npro suppresses IFN-1 pathway signaling in bovine cells and augments BRSV replication.
    Virology. 2017;507:123-134.
    PubMed     Text format     Abstract available
    
    
    June 2017
60. SIKORA D, Rocheleau L, Brown EG, Pelchat M, et al
    Influenza A virus cap-snatches host RNAs based on their abundance early after infection.
    Virology. 2017;509:167-177.
    PubMed     Text format     Abstract available
    
    
    
61. CHLANDA P
    Influenza Hemagglutinin and M2 ion channel priming by trypsin: Killing two birds with one stone.
    Virology. 2017;509:131-132.
    PubMed     Text format     Abstract available
    
    
    
62. PATEL H, Kukol A
    Evolutionary conservation of influenza A PB2 sequences reveals potential target sites for small molecule inhibitors.
    Virology. 2017;509:112-120.
    PubMed     Text format     Abstract available
    
    
    
63. SMITH GE, Sun X, Bai Y, Liu YV, et al
    Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
    Virology. 2017;509:90-97.
    PubMed     Text format     Abstract available
    
    
    
64. DENG L, Kim JR, Chang TZ, Zhang H, et al
    Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.
    Virology. 2017;509:82-89.
    PubMed     Text format     Abstract available
    
    
    May 2017
65. WANG BX, Brown EG, Fish EN
    Residues F103 and M106 within the influenza A virus NS1 CPSF4-binding region regulate interferon-stimulated gene translation initiation.
    Virology. 2017;508:170-179.
    PubMed     Text format     Abstract available
    
    
    
66. SUN X, Belser JA, Pulit-Penaloza JA, Creager HM, et al
    Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
    Virology. 2017;508:164-169.
    PubMed     Text format     Abstract available
    
    
    
67. LIN CY, Chia MY, Chen PL, Yeh CT, et al
    Assessment of pathogenicity and antigenicity of American lineage influenza H5N2 viruses in Taiwan.
    Virology. 2017;508:159-163.
    PubMed     Text format     Abstract available
    
    
    
68. XU G, Zhang X, Liu Q, Bing G, et al
    PA-X protein contributes to virulence of triple-reassortant H1N2 influenza virus by suppressing early immune responses in swine.
    Virology. 2017;508:45-53.
    PubMed     Text format     Abstract available
    
    
    April 2017
69. LEE DH, Torchetti MK, Killian ML, Swayne DE, et al
    Deep sequencing of H7N8 avian influenza viruses from surveillance zone supports H7N8 high pathogenicity avian influenza was limited to a single outbreak farm in Indiana during 2016.
    Virology. 2017;507:216-219.
    PubMed     Text format     Abstract available
    
    
    
70. CHUTIWITOONCHAI N, Mano T, Kakisaka M, Sato H, et al
    Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development.
    Virology. 2017;507:32-39.
    PubMed     Text format     Abstract available
    
    
    
71. HILLYER P, Mane VP, Chen A, Dos Santos MB, et al
    Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.
    Virology. 2017;504:63-72.
    PubMed     Text format     Abstract available
    
    
    March 2017
72. NARKPUK J, Teeravechyan S, Puthavathana P, Jongkaewwattana A, et al
    Single nucleoprotein residue determines influenza A virus sensitivity to an intertypic suppression mechanism.
    Virology. 2017;506:99-109.
    PubMed     Text format     Abstract available
    
    
    
73. FOUGEROLLE S, Legrand L, Lecouturier F, Sailleau C, et al
    Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors.
    Virology. 2017;505:210-217.
    PubMed     Text format     Abstract available
    
    
    February 2017
74. CHEN LJ, Lin XD, Tian JH, Liao Y, et al
    Diversity, evolution and population dynamics of avian influenza viruses circulating in the live poultry markets in China.
    Virology. 2017;505:33-41.
    PubMed     Text format     Abstract available
    
    
    
75. CHAIMAYO C, Hayashi T, Underwood A, Hodges E, et al
    Selective incorporation of vRNP into influenza A virions determined by its specific interaction with M1 protein.
    Virology. 2017;505:23-32.
    PubMed     Text format     Abstract available
    
    
    
76. RODRIGUEZ L, Nogales A, Reilly EC, Topham DJ, et al
    A live-attenuated influenza vaccine for H3N2 canine influenza virus.
    Virology. 2017;504:96-106.
    PubMed     Text format     Abstract available
    
    
    January 2017
77. LEE YH, Jang YH, Seong BL
    Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine.
    Virology. 2017;504:73-78.
    PubMed     Text format     Abstract available
    
    
    
78. PEETERS B, Reemers S, Dortmans J, de Vries E, et al
    Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Virology. 2017;503:83-93.
    PubMed     Text format     Abstract available
    
    
    
79. RABBANI MA, Barik S
    5-Hydroxytryptophan, a major product of tryptophan degradation, is essential for optimal replication of human parainfluenza virus.
    Virology. 2017;503:46-51.
    PubMed     Text format     Abstract available
    
    
    
80. KIM SH, Paldurai A, Samal SK
    A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.
    Virology. 2017;503:31-36.
    PubMed     Text format     Abstract available
    
    
    December 2016
81. PEARCE MB, Pappas C, Gustin KM, Davis CT, et al
    Enhanced virulence of clade 2.3.2.1 highly pathogenic avian influenza A H5N1 viruses in ferrets.
    Virology. 2016;502:114-122.
    PubMed     Text format     Abstract available
    
    
    
82. SUPTAWIWAT O, Ninpan K, Boonarkart C, Ruangrung K, et al
    Evolutionary dynamic of antigenic residues on influenza B hemagglutinin.
    Virology. 2016;502:84-96.
    PubMed     Text format     Abstract available
    
    
    
83. BELSER JA, Sun X, Creager HM, Johnson A, et al
    Role of H7 hemagglutinin in murine infectivity of influenza viruses following ocular inoculation.
    Virology. 2016;502:13-19.
    PubMed     Text format     Abstract available
    
    
    
84. PUSHKO P, Tretyakova I, Hidajat R, Zsak A, et al
    Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
    Virology. 2016;501:176-182.
    PubMed     Text format     Abstract available
    
    
    
85. BAJIMAYA S, Hayashi T, Frankl T, Bryk P, et al
    Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses.
    Virology. 2016;501:127-135.
    PubMed     Text format     Abstract available
    
    
    November 2016
86. HU M, Yuan S, Zhang K, Singh K, et al
    PB2 substitutions V598T/I increase the virulence of H7N9 influenza A virus in mammals.
    Virology. 2016;501:92-101.
    PubMed     Text format     Abstract available
    
    
    
87. LUO J, Ferguson L, Smith DR, Woolums AR, et al
    Serological evidence for high prevalence of Influenza D Viruses in Cattle, Nebraska, United States, 2003-2004.
    Virology. 2016;501:88-91.
    PubMed     Text format     Abstract available
    
    
    
88. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Tretiak T, et al
    Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
    Virology. 2016;500:209-217.
    PubMed     Text format     Abstract available
    
    
    
89. KOSIK I, Yewdell JW
    Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms.
    Virology. 2016;500:178-183.
    PubMed     Text format     Abstract available
    
    
    
90. GONZALEZ Y, Juarez E, Carranza C, Sada E, et al
    Diminished effector and memory CD8+ circulating T lymphocytes in patients with severe influenza caused by the AH1N1 pdm09 virus.
    Virology. 2016;500:139-148.
    PubMed     Text format     Abstract available
    
    
    
91. HARTWIG SM, Ketterer M, Apicella MA, Varga SM, et al
    Non-typeable Haemophilus influenzae protects human airway epithelial cells from a subsequent respiratory syncytial virus challenge.
    Virology. 2016;498:128-35.
    PubMed     Text format     Abstract available
    
    
    October 2016
92. GUJJAR N, Chothe SK, Gawai S, Nissly R, et al
    Co-expression of sialic acid receptors compatible with avian and human influenza virus binding in emus (Dromaius novaehollandiae).
    Virology. 2016;500:114-121.
    PubMed     Text format     Abstract available
    
    
    
93. CREAGER HM, Zeng H, Pulit-Penaloza JA, Maines TR, et al
    In vitro exposure system for study of aerosolized influenza virus.
    Virology. 2016;500:62-70.
    PubMed     Text format     Abstract available
    
    
    
94. NOGALES A, Huang K, Chauche C, DeDiego ML, et al
    Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines.
    Virology. 2016;500:1-10.
    PubMed     Text format     Abstract available
    
    
    
95. ELBAHESH H, Bergmann S, Russell CJ
    Focal adhesion kinase (FAK) regulates polymerase activity of multiple influenza A virus subtypes.
    Virology. 2016;499:369-374.
    PubMed     Text format     Abstract available
    
    
    
96. GARG R, Theaker M, Martinez EC, van Drunen Littel-van den Hurk S, et al
    A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus.
    Virology. 2016;499:288-297.
    PubMed     Text format     Abstract available
    
    
    
97. SHRIVASTAVA P, Sarkar I, Atanley E, Gomis S, et al
    IL-12p40 gene-deficient BALB/c mice exhibit lower weight loss, reduced lung pathology and decreased sensitization to allergen in response to infection with pneumonia virus of mice.
    Virology. 2016;497:1-10.
    PubMed     Text format     Abstract available
    
    
    September 2016
98. CUI P, Deng G, Shi J, Kong H, et al
    New influenza A(H7N7) viruses detected in live poultry markets in China.
    Virology. 2016;499:165-169.
    PubMed     Text format     Abstract available
    
    
    
99. DEJESUS E, Costa-Hurtado M, Smith D, Lee DH, et al
    Changes in adaptation of H5N2 highly pathogenic avian influenza H5 clade 2.3.4.4 viruses in chickens and mallards.
    Virology. 2016;499:52-64.
    PubMed     Text format     Abstract available
    
    
    
100. ISHIKAWA H, Fukui T, Ino S, Sasaki H, et al
     Influenza virus infection causes neutrophil dysfunction through reduced G-CSF production and an increased risk of secondary bacteria infection in the lung.
     Virology. 2016;499:23-29.
     PubMed     Text format     Abstract available
     
     
     
101. RAUFF D, Strydom C, Abolnik C
     Evolutionary consequences of a decade of vaccination against subtype H6N2 influenza.
     Virology. 2016;498:226-239.
     PubMed     Text format     Abstract available
     
     
     April 2016
102. HWANG HS, Lee YT, Kim KH, Park S, et al
     Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
     Virology. 2016;494:215-224.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: